UNIV BUCKINGHAM has a total of 32 patent applications. Its first patent ever was published in 1992. It filed its patents most often in United Kingdom, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DEVARAJAN PRASAD, NETHERLANDS CANCER INST and TARGETED MOLECULAR DIAGNOSTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | New Zealand | 2 | |
#7 | Argentina | 1 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | Czechia | 1 | |
#11 | Hungary | 1 | |
#12 | Israel | 1 | |
#13 | Norway | 1 | |
#14 | Poland | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Foods | |
#6 | Dairy products | |
#7 | Peptides | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Cawthorne Michael Anthony | 18 |
#2 | Emilsson Valur | 10 |
#3 | Morton Nicholas Michael | 9 |
#4 | Davenport Michelle | 6 |
#5 | Dunmore Simon Jon | 6 |
#6 | Stocker Claire Joanne | 3 |
#7 | Michael Morton Nicholas | 1 |
#8 | Cawthorne M A | 1 |
#9 | Morton N M | 1 |
#10 | Emilsson V | 1 |
Publication | Filing date | Title |
---|---|---|
EP1420812A1 | Use of leptin for infant with low birth weight for prevention of obesity | |
GB0120884D0 | Materials and methods for prevention of obesity | |
GB0021414D0 | Methods and compositions relating to body weight and eating disorders II | |
GB0002975D0 | Methods and compositions relating to body weight and eating disorders | |
GB0002973D0 | Method of screening for an agent for treating insulin-related disorders | |
GB9920745D0 | Methods and compositions relating to body weight and eating disorders | |
CZ20004897A3 | Method for detecting a compound that mimics, potentiates or inhibits the physiological effect of leptin | |
GB9914890D0 | Methods and compositions relating to pancreatic islet and -cell dysfunction | |
GB9814199D0 | Novel method | |
NZ334487A | Use of somatostatin type-5 receptor agonist for treating hyperamylinemia | |
GB9213224D0 | Pharmaceuticals and use | |
GB9213225D0 | Pharmaceuticals and use |